placebo controlled Phase

Related by string. * placebos . Placebo . Placebos : placebo controlled clinical trials . blind placebo controlled . double blind placebo / controlling . controller . Controller : randomized controlled trial . obtaining controlled substance . randomized controlled trials / phase . phases . Phases : Phase III clinical trials . Phase III trials * placebo controlled Phase III *

Related by context. Frequent words. (Click for all words.) 75 randomized Phase 75 Phase 2a trial 75 phase IIb 74 pivotal Phase 74 randomized placebo controlled 74 Phase 1b 74 Phase 1b clinical 74 placebo controlled 73 dose escalation trial 73 multicenter randomized double 73 Phase Ib 73 Phase 2a 72 Phase 2a clinical 72 Phase 2b study 72 Phase 2b clinical 72 Phase 2b trial 72 blind randomized placebo 72 Phase 2b 71 Phase III clinical 70 Phase IIa clinical 70 pivotal Phase III 69 randomized double 69 Phase 69 multicenter 69 Phase IIb 69 randomized controlled 69 Phase IIb clinical 69 Phase IIa trial 68 double blind placebo 68 Phase IIb trial 68 Phase III 68 blind randomized 68 Phase IIa 67 dose escalation 67 randomized clinical 67 dose escalation study 67 BAY #-# 67 Phase III pivotal 67 label dose escalation 66 multiple ascending dose 66 DURATION 66 ACTEMRA 66 RG# [001] 65 ISIS # 65 Phase II 65 prospective randomized 65 blind placebo controlled 65 randomized controlled clinical 64 placebo controlled trials 64 single ascending dose 64 HGS ETR1 64 PF # [001] 64 clinical trial 64 Phase III clinical trials 63 ofatumumab 63 lubiprostone 63 Initiates Phase 63 Zerenex 63 eculizumab 63 PRX # 63 eltrombopag 63 randomized 63 Phase III trials 62 confirmatory Phase 3 62 rotigotine 62 CA4P 62 CRx 62 relapsing remitting multiple sclerosis 62 mipomersen 61 unblinded 61 ASA# 61 pegloticase 61 LymphoStat B 61 multicenter study 61 investigational oral 61 AP# [003] 61 ZYBRESTAT 61 sapacitabine 61 MDV# 61 mg BID 61 JANUVIA 60 elagolix 60 pharmacodynamics 60 denufosol 60 randomized clinical trials 60 mcg kg 60 CoFactor 60 randomized #:# 60 MLN# 60 ALKS 60 MGCD# [001] 60 mixed dyslipidemia 60 SEROQUEL 60 evaluable patients 60 investigational compound 60 CYT# 60 myelodysplastic syndromes MDS 60 mg dose 60 bosentan 60 cutaneous T cell 60 adalimumab

Back to home page